RT BSCN (@BSCNews)🚨WALL STREET MEETS STAKINGA new ETF just filed with the SEC would give investors regulated access to staked @Injective INJ! Catch the full breakdown ⬇️https://t.co/DcxmmIYCBs ...

RT BSCN (@BSCNews)🚨 Latest News Podcast: $ETH ETFs Explode!$727M floods into Ethereum ETFs in a single day. Plus, the first-ever U.S. staked INJ ETF filing and moreDon’t get left behind ⬇️https://t.co/Pw49VWjPHo ...

RT BSCN (@BSCNews)🚨WALL STREET MEETS STAKINGA new ETF just filed with the SEC would give investors regulated access to staked @Injective INJ! Catch the full breakdown ⬇️https://t.co/DcxmmIYCBs ...

🚨WALL STREET MEETS STAKINGA new ETF just filed with the SEC would give investors regulated access to staked @Injective INJ! Catch the full breakdown ⬇️https://t.co/DcxmmIYCBs ...

🗞️ Need to catch up on the news? Here's our top 10 from today:🔸 Fed's Waller calls for 25 basis point interest rate cut at the next FOMC meeting in two weeks.🔹 SEC Chair Paul Atkins says the SEC is considering an innovation exception from regulations to promote tokenization, following the House passage of landmark stablecoin legislation.🔸 The White House confirms President Trump supports de minimis tax exemption for Bitcoin and crypto, says they will continue to explore legislative solutions to accomplish i ...

Crypto things you might have missed:-Major updates for the 3 crypto bills🚨-XRP just surpasses $185B for the first time-U.S. accused of dumping BTC holdings-ETH forms golden cross-@CanaryFunds files for staked INJ ETF-Valour launches staked HBAR ETF!LINK IN BIO ...

Key Takeaways HIMS surged 90.4% in three months, outpacing peers and driven by gains in online revenue and subscribers. Expansion into Canada and the ZAVA acquisition mark major international growth milestones for HIMS. HIMS projects up to 74% Q2 revenue growth and 63% full-year growth, fueled by demand for GLP-1 therapies.Hims & Hers Health, Inc.’s (HIMS) investors have been experiencing some short-term gains from the stock lately despite its bumpy ride over recent months. The San Francisco, CA-based hea ...

Canary Capital files for first staked Injective ETF in the US https://t.co/Xwxwj2wZrF ...

- Proven In-Office, Repeatable, Non-Surgical Procedure for the Targeted Delivery of a Wide Variety of Therapies for Serious Retinal Diseases - - CLS-AX Phase 3-Ready Asset with Global Investigator Support and FDA Alignment on Pivotal Trial Program in wet AMD - - Validated Delivery Platform with Five Commercial and Late-Stage Development Suprachoroidal Licensing Collaborations - ALPHARETTA, Ga., July 17, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutio ...

Vancouver, British Columbia--(Newsfile Corp. - July 16, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2025 (Q3). The Company generated revenues of $1.4 million during this period, and an adjusted EBITA loss of $0.1 million. Revenues were driven strongly by sales of DirectInject-LC™, ...